Cellebrite (CLBT) announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. Cellebrite intends to acquire Corellium for an enterprise value of $170 million in cash with $20 million converted to equity at closing. Corellium securityholders will receive up to an additional $30 million in cash based on the achievement of certain performance milestones over the next two years. The deal is expected to close this summer, subject to approval of the Committee on Foreign Investment in the United States and other customary closing conditions. Cellebrite plans to provide additional information about Corellium’s anticipated financial contribution after the transaction closes.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- Cellebrite’s Earnings Call Highlights Growth Amid Challenges
- Cellebrite Reports Strong Q1 2025 Financial Growth
- Cellebrite DI: Buy Rating Affirmed Amid U.S. Federal Growth Opportunities and Strategic Positioning
- Morning Movers: Sony and Dynatrace jump following earnings
- Cellebrite DI: Navigating Challenges with Strong Market Position and Promising Growth Prospects
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue